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Abstract. Extracts from BSC-40 cells infected with 
vaccinia recombinants expressing either the yeast 
KEX2 prohormone endoprotease or a human structural 
homologue (fur gene produc0 contained an elevated 
level of a membrane-associated endoproteolytic a tiv- 
ity that could cleave at pairs of basic amino acids 
(-LysArg- and -ArgArg-). The fur-directed activity (fu- 
fin) shared many properties with Kex2p including ac- 
tivity at pH 7.3 and a requirement for calcium. By 
using antifurin antibodies, immunoblot analysis de- 
tected two furin translation products (90 and 96 kD), 
while immunofluorescence indicated localization to the 
Golgi apparatus. Coexpression of either Kex2p or fu- 
fin with the mouse B-nerve growth factor precursor 
(pro-B-NGF) resulted in greatly enhanced conversion 
of the precursor to mature nerve growth factor. Thus, 
the sequence homology shared by furin and the yeast 
KEX2 prohormone processing enzyme is reflected by 
significant functional homology both in vitro and 
in vivo. 
p OSTTRANSLATIONAL proteolysis a common mecha- nism required for the synthesis of biologically active 
proteins and peptides in all eukaryotes xamined, in- 
cluding yeast (21), invertebrates (56), and mammalian cells 
(17, 62). One of the early events in precursor protein matura- 
tion is endoproteolysis at the carboxyl side of pairs of basic 
amino acid sequences (especially -LysArg- and -ArgArg-). 
This type of endoproteolytic cleavage was initially inferred 
from the sequences ofseveral endocrine and neuroendocrine 
precursor proteins and was first proposed from studies of 
proinsulin (9, 64) and the ACTH/B-endorphin precursor, 
proopiomelanocortin (POMC) t (11). Subsequent studies 
have revealed a broad spectrum of precursor proteins that re- 
quire endoproteolysis at pairs of basic amino acids to yield 
mature peptides, including serum factors (3), viral poly- 
proteins (43, 49, 51, 52), growth factors (24, 26, 58, 75), and 
receptors (76). 
Several activities capable of cleaving at single or paired 
basic residues in vitro have been proposed as candidates for 
authentic mammalian precursor processing endoproteases 
(6, 10, 12-16, 25, 31, 32, 39-41, 46, 47). However, none of 
these candidate activities have been shown to be a bona fide 
precursor cleaving endoprotease in vivo. In contrast, genetic 
(33, 37) and biochemical (20, 22) studies unequivocally 
identified the gene required for excision of the peptide mat- 
Direct all correspondence to Dr. Gary Thomas. 
1. Abbreviations used in this paper: moi, multiplicity of infection; NGF, 
nerve growth factor; POMC, proopiomelanocortin; pro-B-NGE B-nerve 
growth factor precursor; WGA, wheat germ agglutinin. 
ing hormone (a-factor) from its precursor inSaccharomyces 
cerevisiae (baker's yeas0 (for review see reference 21). This 
locus, the KEX2 gene, encodes a unique subtilisin-like, 
membrane-bound, calcium-dependent, serine endoprotease 
(Kex2p) specific for cleaving on the carboxyl side of pairs 
of basic residues (-LysArg- and -ArgArg-) (22). 
Several ines of evidence suggest hat the mammalian 
precursor processing endoprotease(s) is functionally similm 
to Kex2p. The mammalian precursor proalbumin, for exam- 
pie, is efficiently converted in vitro to albumin by Kex2p, 
with cleavage at a paired basic amino acid sequence (-Arg- 
Arg-) (2). Furthermore, coexpression fthe KEX2 gene with 
mouse POMC in BSC-40 cells (a line incapable of process- 
ing this peptide precursor) esulted in efficient proteolysis, 
at pairs of basic amino acids, producing authentic pituitary 
peptides, including ~/-LPH and/~-endorphin 1-31 (68). 
Recently, two human DNA sequences, fur and PC2, have 
been reported which share significant structural homology 
with the KEX2 gene sequence (Fig. 1). The fur locus was 
initially identified by its proximity to the fes/fps proto- 
oncogene (53) and its homology to Kex2p was noted subse- 
quently (23). The DNA sequence of the entire protein 
predicts a translation product, furin (72), which shares 
nearly 50 % overall sequence identity with Kex2p in the 300- 
residue region comprising the catalytic domain, including 
the conserved active site Asp, His, and Ser. PC2 was 
identified by amplification of a human insulinoma library by 
the polymerase chain reaction using KEX2-derived primers 
and also shares ahigh degree of homology with Kex2p, espe- 
cially in the active site domains (59). Both proteins show 
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Figure 1. Schematic representation f furin, 
Kex2p, and PC2. The amino acids forming 
the catalytic triad in the active site are 
shown (/9, aspartate; H, histidine; S, ser- 
ine). Signal sequences are represented as 
solid black boxes and the subtilisin-like do- 
mains are shown as shaded regions. Hatched 
boxes indicate the putative transmembrane 
domains. (q~), potential sites for attach- 
ment of asparagine-linked sugars. See refer- 
ences 72 (furin), 44 (KEX2), and 59 (PC2) 
for predicted protein sequences. 
significantly greater homology to Kex2p than to bacterial 
subtilisins. 
Aside from homology in their catalytic domains, the yeast 
KEX2 gene and human furin eDNA also share very similar 
configurations (Fig. 1). Both proteins have a strongly hydro- 
phobic NH~-terminal sequence. In the case of  Kex2p, this 
segment has been shown to target he protein to the secretory 
pathway, where it becomes glycosylated (20, 22, 23). Both 
proteins also possess a single highly hydrophobic segment 
near the COOH-terminus (44). In Kex2p, this region has 
been shown to be a transmembrane domain responsible for 
anchoring the enzyme in the secretory system, probably the 
Golgi  apparatus (23, 48). Finally, both proteins contain 
highly charged COOH-terminal  tails. 
The sequence homology and shared topology suggested 
that the furin eDNA encodes a Kex2p-l ike protease that 
could be a functional human homologue of Kex2p. Here we 
demonstrate that indeed the furin cDNA encodes a Golgi-  
localized, membrane-associated, ndoprotease that displays 
a substrate specificity, both in vitro and in vivo, similar to 
Kex2p. Possible functions of  furin in mammal ian cells are 
discussed. 
Materials and Methods 
Cell Culture 
BSC-40, an African Green monkey kidney epithelial cell line and ART-20, 
a mouse pituitary corticotroph cell line were cultured as described (68, 70). 
HepG2 cells, a hunma hepatoma, were cultured in MEM containing 10% 
heat inactivated fetal ~:alf serum (HyClone Laboratories, Logan, UT) sup- 
plemented with 0.1 mM pyruvate and 0.1 mM nonessential mino acids 
(Gibco Laboratories, Grand Island, NY). 
Vaccinia Virus 
Vaccinia virus strain WR was used in these studies and infections were per- 
formed as described (68, 70). To construct the vaccinia recombinant ex- 
pressing the human furin eDNA (VV:hFUR), plasmid pBluescript-PACE 
containing the human furin eDNA from which the Y-untranslated region 
was deleted (74) was digested with Sea I and the insert excised by digestion 
with Hinc II and Sma I. Bgl II linkers were ligated on the 2.5-kb insert and 
the fragment was ligated into the vaccinia recombination plasmid, pVV3, 
which was previously cut with Bgl H. The orientation of the ligated eDNA 
was verified and the resulting plasmid pVV3:hFUR was used for marker 
transfer into vaccinia s previously described (29). To construct avaccinia 
recombinant directing expression of the mouse B-nerve growth factor 
precursor (pro-B-NGF) eDNA (VV:mNGF), plasmid pGEM/ngf, contain- 
ing a full-length mouse B-NGF eDNA (71) was digested with Hind HI and 
incubated with Klenow polymerase to generate blunt ends. The linearized, 
blunt-ended fragment was then digested with Bam HI to yield an 820-bp 
insert coding for the shorter transcript of/~-NGF (using the second initiation 
codon) (18). pVV3 plasmid was digested with Bgl II, incubated with I"4 
DNA polymerase to generate blunt ends, and digested with Barn HI. Vector 
and insert were then ligated and a plasmid containing the mNGF insert 
(pVV3:mNGF) was used to introduce the mouse NGF eDNA into vaccinia 
virus by standard marker transfer procedures (29). 
Immunofluorescence 
Cells grown on coverslips were rinsed in PBS (2.8 mM KC1, 1.5 mM 
KH2PO4, 1.4 mM NaC1, 8 mM Na21-IPO4) with 1 mM MgCI2 (PBS-M) 
and fixed for 15 min in PBS-M containing 3% paraformaldehyde plus 1 mM 
CaCI2. After fixation, cells were permeabilized in0.2% BSA, 0.1% Triton 
X-100, 1 mM CaCIe, 1 mM MgCI2, and 1 mM MnCI2 in PBS. Next the 
fixed cells were preincubated in0.1% TX-100 and 2% normal goat serum 
(NGS) to block nonspecitic binding of antibodies. Coverslips were rinsed 
briefly and incubated overnight at 4°C with rabbit antifurin antiserum 
(1:50). The antifurin antibodies were generated against the catalytic domain 
of furin by expression i  l~cherichia coil of amino acids 146-372 of furin 
as a fusion to human superoxide dismutase (74). The furin antiserum was 
preabsorbed with an acetone precipitate of a VV:WT infected BSC-40 cell 
extract and incubated at room temperature for 4 h followed by clarification 
of the antiserum by centrifugation i  a SPIN-X column (Costar, Cambridge, 
MA). After overnight incubation withthe furin antiserum, coverslips were 
then rinsed in permeabilizing solution, incubated with a biotinylated goat 
anti-rabbit antiserum (1:200; Vector Laboratories, Inc., Buflingame, CA) 
for 30 minutes, rinsed and incubated with FITC-conjugated avidin (1:500, 
Vector Laboratories, Inc.) for 50 min. Coverslips were again rinsed and in- 
cubated with wheat germ agglutinin (WGA; diluted 1:50, Molecular Probes 
Inc., Eugene, OR) for 30 rain at room temperature, rinsed, mounted on mi- 
croscope slides in 50% glycerol, and viewed with a Laitz Dialux 22 EB 
fluorescent microscope (63 x objective). 
Cell Fractionation and In Vitro Proteolytic Assays 
BSC-40 cells were grown to comquency on 100-ram plates in MEM contain- 
ing 10% fetal calf serum. Paralld plates were infected with either VV:WT, 
W:KEX2, or W:hFUR at a multiplicity of infection (moi) of 5. At 18 h 
after infection, cells were chilled on ice, rinsed once in ice-cold PBS-M, 
harvested by scraping in 0.5 rni of 10 mM Hepcs, pH 7.3, and lysed with 
20-30 strokes in a Dounce homogenizer (Kontes Glass Co., Vineland, NJ) 
("~70% total lysis as determined by trypan blue exclusion). Lysates were 
cleared by centrifugation atlow speed (1,000 g, 5 rain) to remove cellular 
debris and the crude xtract was transferred toan ultracentrifuge tube. After 
centrifugation at 100,000 g for 60 rain, the supernatant fraction was re- 
moved and the pellet was resuspcnded in 200/~1 of 10 mM Hepes, pH 7.3. 
For assay, 25/zl was placed in 200/zl of sample buffer (100 mM Hepes, 
pH 7.3, 1% Triton X-100, 1 mM CaCI2, 50 #M boc-gly-lys-arg-MCA 
[Peninsula Laboratories, Inc., Belmont, CA]). Samples were incubated for 
30 rain at 370C and the quantity of liberated amino methyl coumarin was 
determined by fluorimetry (excitation ffi 380k, emission = 460),). Protein 
determinations were performed with bicinchoninic acid procedure (61). 
Western Blot 
For immunoblotting, samples containing equivalent amounts of total pro- 
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tein were loaded onto a 10% polyacrylamide g l and run in SDS buffer as 
originally described (54). Protein was then transferred under electric cur- 
rent (24 V) for 16 h at 4"C to nitrocellulose in transfer buffer (39 mM gly- 
cine, 48 mM Tris, 0.037% SDS, 15 % methanol). The blot was preincubated 
in TBST (10 mM Tris-HCl, pH 8, 150 mM NaC1, 0.05% Triton X-100, 
0.02% NAN3) containing 3% dried nonfat milk for 50 rain at room temper- 
attire followed by incubation atroom temperature with primary antibody 
(rabbit antifurin, diluted 1:8,000) for 3 h. After washing three times with 
TBST, the blot was incubated with goat nti-rabbit-alkaline pbosphatase 
and developed (Promega ProtoBlot Immunoblotting system, Promega 
Corp., Madison, WI). 
Northern Blot 
All RNA manipulations were performed as described (54) and as presented 
in the legend to Fig. 4. 
Immunoprecipitations 
Ceils were grown to confluency in MEM containing 10% fetal calf serum 
in 35-ram, 6-well plates. Parallel wells were infected with VV:NGF (moi 
= 2) and either VV:WT, VV:KEX2 or VV:hFUR (moi = 5, total moi = 
7). After 18 h, ceils were starved for 30 min in MEM (-Met, -Cys) + 10% 
dialyzed fetal calf serum, then pulsed for 3 h with [35S]Met,Cys (100 
t~Ci/well; NEN Express Label, DuPont Co., Wilmington, DE). All further 
treatment of samples was at 4"C. Medium was harvested and centrifuged 
for 5 rain at 1,500 g, and transferred to a fresh tube. Samples were then 
centrifuged at 10,000 g for 20 min and transferred to a fresh tube. A pool 
of four anti-B-NGF rat monoclonal antibodies generated to 2.5S NGF was 
added to each sample and incubated for 2 h. A second antibody (rabbit 
anti-rat IgG + M; Zymed Laboratories Inc., South San Francisco, CA) was 
added and samples were incubated for 1 h. Finally, protein A-Sepharose 
was added to each sample and incubated for 1 h. The Sepharose beads were 
washed two times with RIPA buffer (1% NP-40, 1% SDS, 1% sodium deoxy- 
cholate [DOt2], 150 mM NaC1, 50 mM Tris-HCl, pH 8) and two times with 
NET-N (150 mM NaCI, 5 mM EDTA, 50 mM Tris-HC1, pH 8, 0.5 % NP-40, 
0.1% SDS, 0.01% NAN3), and then loaded on 12.5% Laemmii-type SDS 
polyacrylamide gel. 
Results 
To express a functional furin translation product in mam- 
malian cells, the human furin eDNA, isolated from a hepa- 
toma (HepG2) eDNA library (74), was inserted into a vac- 
cinla virus expression vector by standard methods (29). 
Plates of BSC-40 cells were infected either with wild-type 
vaccinia virus (VV:WT), with a vaccinia recombinant con- 
talning the yeast KEX2 gene (VV:KEX2), or with a vaccinia 
recombinant containing the furin eDNA (VV:hFUR). Cells 
were harvested 20 h after infection and crude membrane 
fractions were prepared. Each sample was analyzed for pro- 
teolytic activity capable of cleaving fluorogenic peptide sub- 
strates containing a pair of basic amino acids. Endopro- 
teolytic activity capable of cleaving substrates containing 
LysArg- (Table I) increased 4.9- and 2.3-fold, respectively, 
in cells infected with VV:KEX2 or VV:hFUR. A similar 
stimulation was found for cleavage of substrates containing 
-ArgArg- (data not shown). The increased proteolytic activ- 
ity observed in either VV:KEX2 or VV:hFUR infected cells 
was quantitatively associated with the 100,000-g membrane 
pellet. This selective partitioning to cellular membranes i  
consistent with earlier observations for Kex2p in yeast (20, 
22, 45) and for Kex2p expressed in BSC-40 cells (68). 
In addition to its apparent substrate specificity, furin 
shares other enzymic properties with Kex2p. Kex2p is a ser- 
ine protease that is active at neutral pH, strictly calcium de- 
pendent, and inhibited by only high concentrations of PMSF 
(22, 45; Table I). Similarly, the furin-dependent activity was 
inhibited by EGTA (a calcium chelator) and was active at pH 
Table L Expression f Kex2p and Furin Activity 
in Mammalian Cells 
Condition 
2 mM +3 mM 2 mM Ca ++ 
Virus Ca ++ EGTA + 1 mM PMSF 
HSS WT 12 32 17 
KEX2 56 15 29 
FUR 18 35 24 
HSP WT 109 131 45 
KEX2 533 137 295 
FUR 250 110 64 
Media WT 16 27 21 
KEX2 25 22 24 
FUR 21 23 23 
BSC-40 cells were grown to confluency on 100-mm plates in MEM containing 
10% fetal calf serum. Parallel plates were infected with either VV:WT, 
VV:KEX2 or VV:hFUR (moi = 5). At 18 h after infection crude membrane 
fractions were prepared and proteolytic activity was determined using a small 
fluorogenic substrate (boc-Gly-Lys-Arg-MCA) as described in Materials and 
Methods. Values are listed as enzyme units per milligram protein. One enzyme 
unit equals 1 tool of substrate converted p r minute. Values shown are from 
a single experiment, but qualitatively similar results were obtained in three 
completely independent trials. HSS, high speed superuatant; lISP, high speed 
pellet. 
7.3 (Table I). Unlike the yeast prohormone ndoprotease, 
however, furin activity appeared to be much more sensitive 
to PMSE Neither Kex2p nor furin activity were detected in 
the culture medium (Table I). 
Aliquots of the supernatant and pellet fractions from the 
samples described in Table I, in addition to control samples 
from mock-infected cells, were resolved by one-dimensional 
SDS gel electrophoresis and furin translation products were 
identified by immunoblotting with specific antibodies (Fig. 
2). A doublet of proteins with the apparent sizes of 90 and 
96 kD, respectively, was detected and was found only in the 
membrane fraction from VV:hFUR infected BSC-40 cells 
(Fig. 2, lane 6). These apparent molecular masses are in 
good agreement with the 87-kD translation product predicted 
by the furin eDNA. No furin was detectable by this method 
Figure 2. Immunodetection of furin. High speed supernatant (lanes 
1, 3, and 5) and pellet (lanes 2, 4, and 6) fractions from BSC-40 
cells either mock-infected (lanes 1 and 2) or i fected with VV:WT 
(lanes 3 and 4)or VV:hFUR (lanes 5 and 6) were prepared as de- 
scribed in Table I. PAGE and immunoblotting were prepared as de- 
scribed in Materials and Methods. In a separate experiment the 
high speed pellet prepared from VV:hFUR-infected BSC-40 cells 
in the presence of 1 mM PMSF and'2 #g/nil leupeptin was 
resuspended by Dounce homogenization in 0.1 M sodium carbonate 
(pH 11) followed by recentrifugation at 100,000 g. Proteins from 
the high speed carbonate supematant (lane 7) and pellet (lane 8) 
fractions were precipitated with TCA, resolved by gel electrophore- 
sis, furin protein was identified by Western blot analysis as de- 
scribed in Materials and Methods. 
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in the soluble fractions from these cells or in samples from 
either mock- or VV:WT infected BSC-40 cells (Fig. 2, lanes 
1-5). 
To establish whether furin is tightly associated with mem- 
branes, the 100,000-g pellet prepared in the presence of 
1 mM PMSF and 2 gg/mi leupeptin from BSC-40 cells in- 
fected with VV:hFUR was extracted with 0.1 M sodium car- 
bonate (pH 11) and resedimented at 100,000 g. Western anal- 
ysis demonstrated that the furin doublet was retained in the 
pellet fraction (Fig. 2, compare lanes 7 and 8), as expected 
for the behavior of an integral membrane protein. 
Because Kex2p-dependent precursor cleavage appears to 
occur in the Golgi apparatus in yeast (34), immunofluores- 
cence microscopy was used to determine the subceUular lo- 
calization of furin in mammalian cells. Plates of BSC-40 
cells were infected with either VV:WT or VV:hFUR and the 
fixed cells were stained with antifurin antiserum. Cells in- 
fected with VV:hFUR revealed intense perinuclear staining 
(Fig. 3 A). No detectable staining was evident in control cells 
infected with VV:WT (Fig. 3 C). The fixed cells were also 
incubated with r odamine-coupled wheat germ agglutinin 
(WGA), a specific Golgi compartment marker (28, 73). As 
shown in Fig. 3 B, the pattern of staining by WGA was su- 
perimposable with the localization of furin in BSC-40 cells. 
Thus, as predicted for Kex2p in yeast, furin appears to be 
a Golgi compartment-associated enzyme in mammalian 
cells. 
The structural (Fig. 1) and enzymic properties (Table I) 
shared by the yeast KEX2 endoprotease and furin suggested 
that this novel human endoprotease may be responsible for 
processing precursors containing paired basic sites to pro- 
duce mature bioactive products in the secretory pathway. 
Figure 3. lmmunolocalization of furin. Parallel cultures of BSC-40 cells grown o coverslips were infected with either VV:hFUR (A and 
B ) or VV:WT (C and D) at an moi of 1. AFter 18 h, the cells were fixed in 3 % paraformaldehyde and processed for immunofluorescence 
microscopy as described in Materials and Methods. (A and C). Fluorescein fluorescence (furin antiserum). (B and D). Rhodamine fluores- 
cence (WGA binding). 
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However, a wide variety of precursor proteins, synthesized 
in a large number of endocrine and nonendocrine tissues, re- 
quire endoproteolysis at cleavage sites composed of a dou- 
blet of basic residues. To facilitate identification ofauthentic 
furin substrates, we examined the cell type specificity of fu- 
fin gene xpression. Our initial screening of cell lines indi- 
cated detectable vels of furin transcript in all cell types ex- 
amined including AtT-20 (mouse pituitary corticotroph), 
BSC-40 (African Green monkey kidney epithelial), GH4C1 
(rat pituitary somato/lactotroph), HeLa (human cervical ep- 
ithelial), HepG2 (human hepatoma), L (mouse fibroblast), 
NG108-15 (rat glioma x mouse neuroblastoma hybrid), and 
Rin m5F (rat insulinoma). Fig. 4 shows a comparison of rel- 
ative furin transcript levels in three of these cell lines includ- 
ing the cell line used as a source for the cloned eDNA 
(HepG2) and two cell lines (AtT-20 and BSC-40) previously 
characterized for endogenous precursor protein processing 
capability (67-70). As expected, a 4.5-kb furin transcript 
was detected inpoly A+ RNA from HepG2 cells, the human 
hepatoma cell line from which the furin eDNA was isolated 
(74) (Fig. 4, lane C). This cell line endogenously expresses 
and processes proalbumin at an -ArgArg- site (1, 36). Only 
very low levels of furin transcript were detected in the mouse 
pituitary corticotroph line, AtT-20 (Fig. 4, lane A). These 
cells express high levels of POMC and efficiently process 
this precursor in the regulated secretory pathway (27) at sev- 
eral sites composed of paired basic amino acids (60). Note 
that a second 3.3-kb RNA band, detected only with the AtT- 
20 RNA, hybridized to the radiolabeled furin probe. In- 
terestingly, this species is approximately the size of PC2 
mRNA (59). Whether this band represents PC2, a different 
furin transcript, or yet another KEX2 homologue xpressed 
in endocrine cells remains to be determined. The highest 
levels of furin transcript were found in BSC-40 cells, a 
monkey kidney epithelial line (Fig. 4, lane B). These cells 
possess only a constitutive secretory pathway (70) and are 
incapable of processing certain neuroendocrine peptide 
precursors (including POMC and proenkephalin [67-70]. 
However, BSC-40 cells endogenously express and process 
the transforming growth factor fl precursor (pro-TGF-~) at 
. . . .  ls (24). Furthermore, when ex- 
pressed in BSC-40 cells, the nerve growth factor precursor 
(pro-/~-NGF) was cleaved at a basic residue doublet (Lys ll9- 
Arg t2°, Fig. 5 A) to produce mature/~-NGF (19). One 
potential role, therefore, of the furin endoprotease in mam- 
malian cells is to process growth factor precursors (as op- 
posed to neuropeptide precursors). 
A vaccinia virus recombinant that directs expression ofthe 
mouse pro43-NGF eDNA (VV:mNGF) was constructed to 
study the processing of this precursor protein by furin in the 
mammalian cell secretory pathway. BSC-40 cells were 
selected since this cell line was used to document vaccinia- 
derived furin expression (Table I; Figs. 2 and 3), possesses 
only the constitutive secretory pathway (70) and is amenable 
to infection with multiple vaccinia recombinants (68). 
Replicate plates of BSC-40 cells were infected with either 
VV:WT or VV:mNGF or both, and at increasing times after 
virus infection each culture was metabolically labeled for 
3 h with [35S]methionine. The secreted products were im- 
munoprecipitated with pooled monoclonal ntibodies direct- 
ed against/3-NGF and resolved by SDS gel electrophoresis. 
In agreement with earlier studies (19), metabolic labeling of 
BSC-40 ceils at short times after infection (3 h) resulted in 
expression of pro-/3-NGF and efficient processing of the pro- 
hormone to mature 13-kD/3-NGF peptide, presumably by 
Figure 4. Analysis of furin 
mRNA. 5 /~g of poly A ÷ RNA 
isolated from AtT-20 (A), BSC- 
40 (B), and HepG2 (C) cells 
was denatured with formalde- 
hyde, subjected to electrophore- 
sis in a 1% agarose gel, trans- 
ferred to a nylon membrane 
(Hybond-N; Amersham Corp., 
Arlington Heights, IL), and hy- 
bridized with a random-prime 
32p-labeled insert containing the 
hfur cDNA sequence. After ex- 
posure to x-ray film, the blot was 
stripped and rehybridized with a 
random-primed 32p-labeled probe 
of the 1B15 (cyclophilin) sequence to nsure that equal levels of 
RNA were loaded initially, hfurin mRNA migrates at 4.5 kb. 11315 
migrates at 1 kb. 
Figure 5. Processing of pro-~-NGF by Kex2p and furin in vivo. (A) 
Schematic of pro-/3-NGF expressed from VV:mNGF vector (14), 
with cleavage sites at paired basic amino acids (vertical bars) and 
mature /3-NGE (B) Immunoprecipitation of /J-NGF from the 
medium of BSC-40 cells infected with (/) VV:WT + VV:mNGE 
(2) VV:KEX2 + VV:mNGE or (3)VV:hFUR + VV:mNGE Im- 
munoprecipitations were performed as described in Materials and 
Methods using an equal volume of dia from equal amounts of 
cells. Pro-/3-NGF migrates as a 35--40-kD band, whereas mature 
/$-NGF migrates as a 13-kD band. Processing intermediates appear 
at 18 and 20 kD. 
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the endogenous furin enzyme present. However, when label- 
ing was initiated at a later time (19-h postinfection), the rate 
of pro-/~-NGF synthesis was significantly higher and the ma- 
jor secreted product was unprocessed precursor (Fig. 5 B, 
lane/). This observation provided a means to examine the 
effect of elevated furin protease activity on the efficiency of 
processing of pro-/~-NGE 
Either Kex2p or furin was coexpressed with pro-/~-NGF 
in BSC-40 cells. 18 h after infection, each sample was in- 
cubated for 3 h with [35S]methionine and/3-NGF-containing 
peptides were immunoprecipitated from the culture media 
using pooled monoclonal ntibodies directed against/3-NGE 
Under these conditions, coexpression of Kex2p together 
with pro-/3-NGF markedly increased processing of pro-/~- 
NGF to mature (13 kD) fl-NGF peptide (Fig. 5 B, lane 2). 
In addition, two peptides of 18 and 20 kD were also immuno- 
precipitated. These peptides probably represent processing 
intermediates resulting from cleavage within the proregion 
of the precursor (32). Thus, Kex2p, which can efficiently 
process mouse POMC in mammalian cell (68), also can pro- 
cess pro-/~-NGF to/3-NGF peptide. Strikingly, coexpression 
of human furin and pro-/~-NGF resulted in complete conver- 
sion of pro-B-NGF to smaller peptides, primarily 13-kD 
~-NGF (Fig. 5 B, lane 3). As a control to ensure that he ap- 
parent pro-/3-NGF processing was not occurring in the me- 
dium after secretion, labeled pro-/3-NGF from the culture 
medium of VV:mNGF-infected cells was transferred toplates 
of either VV:WT- or VV:hFUR-infected cells. Analysis of 
this material after 3 h of incubation demonstrated that pro- 
/~-NGF was completely stable in the culture medium. 
Comparison of the 13-kD ~-NGF to 35-kD pro-/~-NGF by 
densitometric analysis revealed that in the sample from cells 
coinfected with VV:mNGF and VV:WT, only 23% of the 
radioactivity was present as 13-kD/$-NGF; in marked con- 
trast in cells coinfected with VV:mNGF and VV:KEX2 or 
VV:hFUR, the fraction of radioactivity present as 13-kD 
/$-NGF was 79 and >98%, respectively. The processed NGF 
in the medium from cells coinfected with VV:mNGF and 
VV:hFUR was biologically active as determined by its abil- 
ity to induce neurite outgrowth on chick dorsal root ganglia, 
whereas medium from cells infected with VV:WT alone 
was negative for this biologic activity (Bresnahan, P., and 
G. Thomas, unpublished results). Because the vaccinia- 
produced furin activity measured by in vitro assay of the in- 
fected cells was substantially lower than vaccinia produced 
Kex2p activity (Table I), yet pro-/~-NGF conversion was 
complete in the furin producing ceils but not in the Kex2p- 
producing cells, the human endoprotease appears to be a 
more efficient processing enzyme for this precursor in BSC- 
40 cells. 
Discussion 
Our results demonstrate that he human furin cDNA isolated 
from HepG2 cells encodes a Golgi compartment-localized 
membrane-associated, calcium-dependent, serine protease. 
In agreement with the reported structural homology between 
furin and the yeast KEX2 prohormone ndoprotease (23, 
72), we show that both enzymes share significant functional 
homology in vitro (Table I) and in vivo (Fig. 5). 
The Western blot analysis in Fig. 2 revealed two prominent 
furin translation products (90 and 96 kD) present in crude 
membrane fractions of VV:hFUR-infected BSC-40 cells. 
The cause of the size heterogeneity s not yet known. One 
possibility is that the doublet may result from heterogeneity 
in posttranslational modifications (e.g., note in Fig. 1 the 
multiple sites for attachment of asparagine-linked sugars). 
However, the doublet is still present after treatment with 
N-glycanase (74). A second possibility is that he initial furin 
translation product is actually an inactive zymogen which 
becomes activated by endoproteolytic cleavage. Indeed, au- 
toproteolytic removal of the entire amino terminal extension 
is required for activation of the structurally related bacterial 
subtilisin precursor (30, 50). Similarly, the precursor of 
Kex2p protease undergoes removal of an NH2-terminal pro- 
peptide, probably by an autoproteolytic mechanism (Wilcox, 
C. A., and R. S. Fuller, personal communication). The furin 
cDNA sequence predicts a small cluster of paired basic 
amino acids at nearly the identical position as found in KEX2. 
Cleavage at either of these sequences would generate a pro- 
tein ,o6 kD smaller than the primary translation product (the 
same size difference detected in Fig. 2). The observed ou- 
blet is not likely to be merely an artifact of sample prepara- 
tion because it was found when harvesting in the presence 
of protease inhibitors (Fig. 2) or when the cells were ex- 
tracted directly with buffer containing 2% SDS at 70°C 
(Leduc, R., and G. Thomas, unpublished results). 
The preferential localization of furin to the Golgi appara- 
tus of BSC-40 cells (Fig. 3) suggests conserved mechanisms 
for intracellular targeting of processing proteases between 
yeast and humans. IntraceUular retention of Kex2p in the 
Golgi apparatus of Saccharomyces cerevisiae is required for 
efficient maturation of a-mating factor. Yeast mutants lack- 
ing clathrin heavy chain are unable to retain Kex2p intracel- 
lularly, resulting in deficient processing of the pro-a-mating 
pheromone (48). Similarly, deletions of the Kex2p cytoplas- 
mic tail also result in mislocalization of the protease and 
inefficient processing of the pro-cr-mating pheromone (23). 
The observation that both Kex2p and furin share a highly 
charged cytoplasmic tail, including conserved tyrosine 
residues (23, 72), suggests that the furin cytoplasmic tall 
may also be required for retention of this protease in the 
Golgi compartment. Golgi compartment localization of fu- 
rin in our experiments is unlikely to be an artifact of over- 
production of the protein because several other proteins of 
known subcellular localization reach their proper destination 
when produced from vaccinia expression vectors. For exam- 
ple, in polarized epithelial cells, VSV-G protein and in- 
fluenza virus HA antigen are correctly targeted to the baso- 
lateral and apical membranes, respectively, when expressed 
by vaccinia virus recombinants (65). Likewise, addition of 
the KDEL endoplasmic retention signal onto a soluble form 
of CD4 expressed from vaccinia confers retention of this pro- 
tein to the ER (7). The actual compartment i  which furin- 
directed proteolysis occurs remains to be determined. How- 
ever, the apparent localization to the Golgi compartment and 
substrate specificity of this endoprotease correlates with the 
reported endoproteolysis of several retroviral envelope pro- 
teins (including RSV Pr95 [49] and HIV gpl60 [63]), which 
apparently requires a -LysArg- directed endoprotease and 
takes place in the Golgi apparatus. 
Processing of peptide precursors at pairs of basic residues 
has been studied most extensively in endocrine cell lines 
The JourNal of Cell Biology, Volume 111, 1990 2856 
where efficient processing of neuroendocrine prohormones 
is restricted to the regulated secretory pathway (8, 27, 35). 
When missorted into the constitutive secretory pathway, pro- 
hormone molecules are not processed, but secreted as the in- 
tact precursor (27, 70). However, processing of other precur- 
sor proteins at doublets of basic residues occurs in cells that 
lack the regulated secretory pathway (e.g., BSC-40, L, 
HeLa) including pro-/3-NGF (19; Fig. 5), pro-TGF-~ (58), 
proalbumin (1, 36), pro-von Willebrand factor (5, 74), insu- 
lin proreceptor (76), and several retroviral envelope proteins 
(e.g., HIV gpl60) (43, 49, 51, 52). The widespread tissue 
distribution of this large class of precursor proteins suggests 
that the cognate endoprotease(s) must also be present in a 
wide variety of tissue and cell types. Consistent with these 
findings, furin mRNA is found ubiquitously in all cultured 
cell lines tested, although markedly different levels of ex- 
pression are observed (Fig. 4; and Thomas, L., and G. 
Thomas, unpublished results). 
While both prohormone (e.g., POMC) and other precur- 
sors (e.g., pro-/3-NGF) require proteolysis at paired basic 
amino acids to liberate biologically active polypeptl.des, the 
dependence of prohormone processing on localization to the 
regulated secretory pathway suggests a specific mechanism 
for maturation of this class of substrate. This restriction may 
arise from: (a) structural differences in the precursor mole- 
cules, including sequences in the vicinity of the processing 
site or higher order structural properties (e.g., folding); (b) 
differential compartmentalization of the substrate and the 
processing enzyme(s); or, perhaps, (c) expression of distinct 
processing enzymes in the regulated pathway. One notable 
structural similarity shared by several "nonhormone" sub- 
strates, including the precursors for factor IX (3), insulin 
receptor (76), endothelin (75), TGF-~ (58), EGF (26), 
/5-NGF (4), brain-derived neurotropic factor (BDNF) (38), 
neurotrophin 3 (42), and HIV gpl60 (43), is an arginine lo- 
cated four residues amino-terminal to the paired basic cleav- 
age site (-Arg-X-Lys/Arg-Arg-). The lack of processing of a 
mutant pro-factor IX (Arg-Pro-Lys-Arg-~ -Gln-Pro-Lys- 
Arg-) suggests that this residue is required (3). In contrast, 
the neuroendocrine prohormone, prosomatostatin, is not 
processed in fibroblasts (57) even though it possesses an ar- 
ginine residue four amino acids amino-terminal to the paired 
basic cleavage site. However, the apparent processing site on 
prosomatostatin is an -Arg-Lys- sequence, not -LysArg- or 
-ArgArg- typically found in nonhormone precursors. Muta- 
tion of this -ArgLys- site in prosomatostatin to -ArgArg- or 
-LysArg- results in a partial processing of this prohormone 
in fibroblast ceils (66) suggesting that -ArgArg- or -LysArg- 
are indeed the preferred sites for the processing enzyme in 
the constitutive pathway, presumably furin. 
Consistent with this view, using pro-~-NGF as a model 
substrate, we demonstrated that furin expressed in a recom- 
binant vaccinia vector ett~cienfly processed a mammalian 
precursor protein in the constitutive secretory pathway of 
BSC-40 cells. Taken together, the results presented here un- 
equivocally identify furin as the initial member of a unique 
family of mammalian proteases capable of processing pre- 
cursor proteins in the secretory pathway. 
The authors thank Dr. Rae Nishi (Oregon Health Services University, Port- 
land, OR) for the generous gift of anti-NGF monoclonal antibodies and 
help with the dorsal root ganglia bioassay, Dr. A. Ullrich (Max Planck, 
Munich, Federal Republic of Germany) for the pro-~-NOF cDNA, and Dr. 
J. Garrett (Oregon Health Services University) for plasmid pGEM/ngf. We 
acknowledge Paul Keating for photography. We also thank B. A. Thorne, 
J. Hayflick, and M. Forte for critical reading of the manuscript; colleagues 
at Chiron for assistance, valuable comments, and support; and R. S. Fuller 
for communication f results before publication. 
This work was supported by a Fonds de la Recherche n Sant~ du Que- 
bec Fellowship 890315 (to R. Leduc) and National Institutes of Health 
(NIH) grant GM-21841 (to J. Thorner) and NIH grant DK-37274, NIH 
grant BRSG RR 07238, and Oregon Medical Research Foundation 892 to 
G. Thomas. 
Received for publication 27 July 1990 and in revised form 13 September 
1990. 
References 
1. Aden, D. P., A. Fogel, S. Plotkin, I. Damjanov, andB. C. Knowles. 1979. 
Controlled synthesis ofHBsAg in a differentiated human liver carcinoma- 
derived cell line. Nature (Lond.). 282:615-616. 
2. Bathurst, I. C., S. O. Brennan, R. W. Carreil, L. S. Cousens, A. J. Brake, 
and P. J. Ban-. 1986. Yeast KEX2 protease has the properties of a human 
proalbumin converting enzyme. Science (Wash. DC). 235:348-350. 
3. Bentley, A. K., D. J. (3. Rees, C. Rizza, and G. G. Brownlee. 1986. Defec- 
tive propeptide processing ofblood clotting factor IX caused by mutation 
of arginine to ghitamine at position -4 .  Cell. 45:343-348. 
4. Berger, E. A., and E. M. Shooter. 1977. Evidence for pro-0-nerve growth 
factor, a biosynthetic precursor E-nerve growth factor. Proc. Natl. Acad. 
Sci. USA. 74:3647-3651. 
5. Bonthron, D. T., R. I. Handin, R. J. Kaufman, L. C. Wasley, E. C. Orr, 
L. M. Mitsock, B. Erwenstein, J. Loscalzo, D. Oinsberg, and S. H. Or- 
kin. 1986. Structure of pre-pro-von Willebrand factor and its expression 
in heteroiogous cells. Nature (Lond.). 324:270-273. 
6. Brennan, S. O., and R. J. Peach. 1988. Calcium-dependem KEX2-1ike pro- 
tease found in hepatic secretory vesicles converts proalbumin toalbumin. 
FEBS (Fed. Eur. Biochem. Soc.) Lett. 229:167-170. 
7. Buonocore, L., and J. K. Rose. 1990. Prevention of HIV-I glycoprotein 
transport by soluble CD4 retained in the endoplasmic reticulum. Nature 
(Lond.). 345:625-628. 
8. Burgess, T. L., and R. B. Kelly. 1987. Constitutive and regulated secretion 
of proteins. Annu. Rev. Cell Biol. 3:243-293. 
9. Chance, R. E., R. M. Ellis, and W. W. Bromer. 1968. Porcine proinsulin: 
characterization a d amino acid sequence. Science (Wash. DC.). 161: 
165-167. 
10. Chang, T. L. and Y. P. Loh. 1984. In vitro processing ofproopiocor- 
tin by membrane-associated nd soluble converting enzyme activities 
from rat intermediate lobe secretory granules. Endocrinology. 114: 
2092-2099. 
11. Chretien, M., and C. H. Li. 1967. Isolation, purification, and characteriza- 
tion of 3,-lipotrophic hormone from sheep ituitary glands. Can. J. Bio- 
chem. 45:1163-1174. 
12. Clamagirand, C. Creminson, C. Fahy, H. Beussetta, nd P. Cohen. 1987. 
Partial purification and functional properties of an endoprotease from bo- 
vine neurosecretory granules cleaving proocytocin/neurophysin peptides 
at the basic amino acid doublet. Biochemistry. 26:6018-6023. 
13. Cromlish, J. A., N. G. Seidah, and M. Chretien. 1986. A novel serine pro- 
tease (IRCM-serine protease 1) from porcine neurointermediate ndan- 
terior pituitary lobes. J. Biol. Chem. 261:10850-10858. 
14. Darling, T. L. J., P. E. Petrides, P. Beguin, P. Frey, E. M. Shooter, M. 
Selby, and W. J. Rutter. 1983. The biosynthesis and processing of pro- 
teins in the mouse 7S nerve growth factor complex. Cold Spring Harbor 
Symp. Quant. Biol. 48:427--434. 
15. Davidson, H. W., M. Peshavaria, nd J. C. Hutton. 1987. Proteolytic on- 
version of proinsulin into insulin. Identification of a Ca2+-dependent 
acidic endopeptidase in isolated insulin-secretory granules. Biochem. J. 
246:279-286. 
16. Docherty, K., J. C. Hutton, and D. F. Steiner. 1984. Cathepsin B-related 
proteases in the insulin secretory granule. J. Biol. Chem. 259:6041- 
6044. 
17. Douglass, J., O. Civelli, and E. Herbert. 1984. Polyprotein gene expres- 
sion: generation ofdiversity of neuroendocrine peptides. Annu. Rev. Bio- 
chem. 53:665-715. 
18. Edwards, R. H., M. J. Selby, and W. J. Rutter. 1986. Differential RNA 
splicing predicts two distinct nerve growth factor precursors. Nature 
(Lond.). 319:784-787. 
19. Edwards, R. H., M. J. Selby, W. C. Mobley, S. L. Weinrich, D. E. Hruby, 
and W. J. Rutter. 1988. Processing and secretion of nerve growth factor: 
expression i mammalian cells with a vaccinia virus vector. Mol. Cell. 
Biol. 8:2456-2464. 
20. Fuller, R., A. Brake, and J. Thorner. 1986. The Saccharomyces cerevisiae 
KEX2 gene, required for processing prepro-ot-factor, encodes a calcium- 
Bresnahan et al. Human Furin Encodes KEX2-like Endoprotease 2857 
dependent endopeptidase that cleaves after Lys-Arg and Arg-Arg se- 
quences. In Microbiology. L. Leive, editor. American Society for 
Microbiology, Washington, DC. 273-278. 
21. Fuller, R. S., R. E. Sterne, and J. Thoruer. 1988. Enzymes required for 
yeast prohormone processing. Annu. Rev. Physiol. 50:345-362. 
22. Fuller, R. S., A. Brake, and J. Thorner. 1989. Yeast probormone process- 
ing enzyme (KEX2 gene product) is a Ca2+-dependent serine protease. 
Proc. Natl. Acad. Sci. USA. 86:1434-1438. 
23. Fuller, R. S., A. Brake, and J. Thorner. 1989. Intracellular targeting 
and structural conservation of a prohormone-processing eodoprotease. 
Science (Wash. DC). 246:482-485. 
24. Gentry, L. E., M. N. Lioubin, A. F. Purchio, and H. Marquardt. 1988. 
Molecular events in the processing of recombinant type 1 pre-pro- 
transforming growth factor beta to the mature polypeptide. Mol. Cell. 
Biol. 8:4162-4168. 
25. G|uschankof, P., S. Gomez, A. Morel, and P. Cohen. 1987. Enzymes that 
process omatostatin precursors. J. Biol. Chem. 262:9615-9620. 
26. Gray, A., T. J. Dull, and A. Ullrich. 1983. Nucleotide sequence ofepider- 
mal growth factor eDNA predicts a 128,000-molecular weight protein 
precursor. Nature (Lond. ). 303:722-725. 
27. Gumbiner, B., and R. B. Kelly. 1982. Two distinct intracellular pathways 
transport secretory and membrane glycoproteins to the surface of pitu- 
itary tumor cells. Cell. 28:51-59. 
28. Hardwick, J. M., K. E. S. Shaw, J. W. Wills, and E. Hunter. 1986. Amino- 
terminal deletion mutants of the Rous sarcoma virus glycoprotein do not 
block signal peptide cleavage but can block intracellular t ansport. J. Cell 
Biol. 103:829-838. 
29. Hroby, D. E., G. Thomas, E. Herbert, and C. A. Franke. 1986. Use of 
vaccinia virus as a neuropeptide expression vector. Methods Enzymol. 
124:295-309. 
30. Ikemura, H., and M. Inouye. 1988. In vitro processing of pro-subtilisin 
produced in Escherichia coli. J. Biol. Chem. 263:12959-12963. 
31. Isackson, P. J., J. C. Dunbar, and R. A. Bradshaw. 1978. Role of glandular 
kallikreins as growth factor processing enzymes: structural and evolu- 
tionary considerations. J. Cell Biochem. 33:65-75. 
32. Jongstra-Bilen, J. L. Coblentz, and E. M. Shooter. 1989. The in vitro pro- 
cessing of the NGF precursors by the 7-subunit oftbe 7S NGF complex. 
Mol. Brain Res. 5:159-169. 
33. Julius, D., A. Brake, L. Blair, R. Kunisawa, and J. Thorner. 1984. Isola- 
tion of the putative structural gene for the lysine-arginine-cleaving e - 
dopeptidase required for processing of yeast prepro-ct-factor. Cell. 
37:1075-1089. 
34. Julius, D., R. Schekman, and J. Thorner. 1984. Glycosylation and process- 
ing of prepro-ct-factor through the yeast secretory pathway. Cell. 36: 
309-318. 
35. Kelly, R. B. 1985. Pathways of protein secretion in eukaryotes. Science 
(Wash. DC). 230:25-32. 
36. Knowles, B. B., C. C. Howe, D. P. Aden. 1980. Human hepatocellular 
carcinoma cell lines secrete the major plasma proteins and hepatitis B sur- 
face antigen. Science (wash. DC). 209:497-499. 
37. Leibowitz, M. J., and R. B. Wickner. 1976. A chromosomal gene required 
for killer plasmid expression, mating, and spore maturation i  Sac- 
charomyces cerevisiae. Proc. Natl. Acad. Sci. USA. 73:2061-2065. 
38~ Leibrock, J., F. Lottspeich, A. Hohn, M. Hofer, B. Hengerer, P. 
Masiakowski, H. Thocnen, and Y. A. Barde. 1989. Molecular cloning 
and expression of brain-derived neurotrophic factor. Nature (Loud.). 
341:149-152. 
39. Lindberg, 1., H.-Y. T. Yang, and E. Costa. 1984. Further characterization 
of an enkephalin-generating enzyme from adrenal medullary chromaflin 
granules. J Neurochem. 42:1411-1419. 
40. Loh, Y. P. 1986. Kinetic studies on the processing of human/5-1ipetropin 
by bovine pituitary intermediate lobe pro-opiomelanocortin-converting 
enzyme. J Biol. Chem. 261 :11949-11955. 
41. Mason, A. J., B. A. Evans, D. R. Cox, J. Shine, and R. L Richards. 1983. 
Structure of mouse kaUikrein gene family suggests a role in specific pro- 
cessing of biologically active peptides. Nature (Loud.). 303:300-306. 
42. Maisonpeirre, P. C., L. Belluscio, S. Squinto, N. Y. Ip, M. E. Furth, 
R. M. Lindsay, G. D. Yancopoulos. 1990. Neurotrophin-3: a neuro- 
trophic factor related to NGF and BDNF. Science (Wash. DC). 247: 
1446-1451. 
43. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, 
G. R. Reyes, and I. R. Weissman. 1988. Endoproteolytic cleavage of 
gplt0 is required for the activation of human immunodeficiency virus. 
Cell. 53:55-67. 
44. Mizuno, K., T. Nakamura, T. Ohshima, S. Tanaka, and H. Matsuo. 1988. 
Yeast KEX2 genes encodes an endopeptidase homologous to subtilisin- 
like serine proteases. Biochem. Biophys. Res. Commun. 156:246-254. 
45. Mizuno, K., T. Nakamura, T. Ohshima, S. Tanaka, and H. Matsuo. 1989. 
Characterization of KEX2-encoded endopeptidase from yeast Sac- 
charomyces cerevisiae. Biochem. Biophys. Res. Commun. 159:305-311. 
46. Nee, B. D., G. Debo, and J. Spiess. 1984. Comparison of prohormone- 
processing activities in islet microsomes and secretory granules: evidence 
for distinct converting enzymes for separate islet prosomatostatins. J. 
Cell Biol. 99:578-587. 
47. Parish, D. C., R. Tnteja, M. Altstein, H. Gainer, and Y. P. Loh. 1986. 
Purification and characterization f a paired basic residue-specific 
prohormone-converting enzyme from bovine pituitary neural lobe secre- 
tory vesicles. J Biol. Chem. 261:14392-14397. 
48. Payne, G. S., and S. Schekman. 1989. Clathrin: a role in the intracellular 
retention of a Golgi membrane protein. Science (Wash. DC). 245:1358- 
1365. 
49. Perez, L. G., and E. Hunter. 1987. Mutations within the proteolytic cleav- 
age site of the rous sarcoma virus glycoprotein that block processing to 
gp85 and gp37. J. Virol. 61:1609-1614. 
50. Power, S. D., R. M. Adams, and J. A. Wells. 1986. Secretion and au- 
toproteolytic maturation of subtilisin. Proc. Natl. Acad. Sci. USA. 
83:3096-3100. 
51. Rice, C. M., E. M. Lenches, S. R. Eddy, S. J. Shin, R. J. Sheets, and 
J. H. Strauss. 1985. Nucleotide sequence ofyellow fever virus: implica- 
tions for flavivirus gene expression and evolution. Science (Wash. DC). 
229:726-733. 
52. Rice, C. M., R. Aebersold, D. B. Teplow, J. Pata, J. R. Bell, A. V. Vorn- 
dan, D. W. Trent, M. W. Brandriss, J. J. Schlesinger, and J. H. Strauss. 
1986. Partial n-terminal mino acid sequences ofthree nonstructural pro- 
teins of two fiaviviruses. Virology. 151 :1-9. 
53. Roebroek, A. J. M., J. A. Schalken, J. A. M. Leunissen, C. Onnekink, 
H. P. J. Bloemers, and W. J. M. Van de Ven. 1986. Evolutionary con- 
served close linkage of the c-fed/fps proto-oncogene and genetic se- 
quences encoding a receptor-like protein. EMBO (Eur. Mol. Biol. Or- 
gan.) J. 5:2197-2202. 
54. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular Cloning: 
A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Har- 
bor, NY. 7.43-7.52. 
55. Schalken, J. A., A. J. M. Roebroek, P. P. C. A. Oomen, S. S. Wagenaar, 
F. M. J. Debruyne, H. P. J. Bloemers, and W. J. M. Van de Ven. 1987. 
fur Gene expression as a discriminating marker for small cell and non- 
small cell lung carcinomas. J. Clin. Invest. 80:1545-1549. 
56. Scheller, R. H., J. F. Jackson, L. B. McAllister, B. S. Rothman, E. 
Mayeri, and R. Axel. 1983. A single gene encodes multiple neuropep- 
tides mediating a stereotyped behavior. Cell. 32:7-22. 
57. Sevarino, K. A., R. Felix, C. M. Banks, M. J. Low, M. R. Montminy, 
G. Mandel, and R. H. Goodman. 1987. Cell-specific processing of 
preprosomatostatin in cultured neuroendocrine c lls. J. Biol. Chem. 
262:4987-4993. 
58. Sharpies, K., G. D. Plowman, T. M. Rose, D. M. Twardzik, and A. F. 
Purchio. 1987. Cloning and sequence analysis of simian transforming 
growth factor-~ eDNA. DNA (NY). 6:239-244. 
59. Smeekens, S. P., and D. F. Steiner. 1990. Identification of a human insuli- 
noma eDNA encoding a novel mammalian protein structurally related 
to the yeast dibasic processing protease Kex2. J. Biol. Chem. 265: 
2997-3000. 
60. Smith, A. I., and J. W. Funder. 1988. Proopiomelanocortin processing in
the pituitary, central nervous ystem, and peripheral tissues. Endocr. 
Rev. 9:159-179. 
61. Smith, P. K., R. I. lO'olm, G. T. Hermanson, A. K. Mallia, F. J. Gartner, 
M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. 
Klenk. 1985. Measurement of protein using bicinchoninic acid. Anal. 
Biochem. 150:76-85. 
62. Sossin, W. S., J. M. Fisher, and R. H. Scheller. 1989. Cellular and molecu- 
lar biology of neuropeptide processing and packaging. Neuron. 2:1407- 
1417. 
63. Stein, B. S., and E. G. Engleman. 1990. Intracellular processing of the 
hgplt0 HIV-1 envelope precursor. J Biol. Chem. 265:2640-2649. 
64. Steiner, D. F., D. Cunningham, L. Spigelman, and B. Aten. 1967. Insulin 
biosynthesis: evidence for a precursor. Science (Wash. DC). 157:697- 
700. 
65. Stephens, E. B., R. W. Compans, P. Fad, and B. Moss. 1986. Surface x- 
pression of viral glycoproteins is polarized in epithelial cells infected with 
recombinant vaccinia viral vectors. EMBO (Fur. Mol. Biol. Organ.) J. 
5:237-245. 
66. Stoller, T. J., and D. Shields. 1989. The role of paired basic amino acids 
in mediating proteolytic leavage of prosomatostatin. J. Biol. Chem. 
264:6922-6928. 
67. Thomas, G., E. Herbert, and D. E. Hruby. 1986. Expression and cell type- 
specific processing of human preprocnkephalin with a vaccinia recom- 
binant. Science (wash. DC). 232:1641-1643. 
68. Thomas, G., B. A. Thorne, L. Thomas, R. G. Allen, D. E. Hruby, R. 
Fuller, and J. Thorner. 1988. Yeast KEX2 endopeptidase correctly 
cleaves a neuroendocrine prohormone in mammalian cells. Science 
(wash. DC). 241:226-241. 
69. Thomas, G., B. A. Thorue, and D. E. Hruby. 1988. Gene transfer tech- 
niques to study neuropeptide processing. Anna. Rev. Physiol. 50:323- 
332. 
70. Thorne, B. A., L. W. Caton, and G. Thomas. 1989. Expression of mouse 
proopimelanocortin in an insulinoma cell line. J. Biol. Chem. 264: 
3545-3552. 
71. Ullrich, A., A. Gray, C. Berman, and T. J. Dull. 1983. Human t-nerve 
growth factor gene sequence highly homologous tothat of mouse. Nature 
(Loud.). 303:821-825. 
72. van den Ouweland, A. M. W., H. L. P. van Duijnhoven, G. D. Keizer, 
The Journal of Cell Biology, Volume 111, 1990 2858 
L. C. J. Dorssers, and W. J. M. Van de Ven. 1990. Structural homology 
between the human fur gene product and the subtilisin-like protease n- 
coded by yeast KEX2. Nucleic Acids Res. 18:664. 
73. Virtanan, I., P. Ekblom, and P. Lauriai. t986. Subeellular compartmental- 
ization of saccharide moieties in cultured normal and malignant cells. J. 
Cell Biol, 85:429-434. 
74. Wise, R. J., P. J. Barr, P. A. Wong, M. C. Kiefer, A. J. Brake, and 
R. J. Kanfmann. 1990. Expression of a human proprotein processing en- 
zyme: Correct cleavage of the yon Willebrand factor precursor ata paired 
basic amino acid site. Proc. Natl. Acad. Sci. USA. In press. 
75. Yanagisawa, M., A. Inoue, T. lshikawa, Y. Kasuya, S. Kimura, S. I. 
Kumagaye, K. Nakajima, T. X. Watanabe, S. Sakakibara, K. Goto, and 
T. Masaki. 1988. Primary structure, synthesis, and biological activity of 
rat endothelin, and endothelium-derived vasoconstrictor pcptide. Proc. 
Natl. Acad. Sci. USA. 85:6964-6967. 
76. Yoshimasa, Y., S. Seino, J. Whittaker, T. Kakehi, A. Kosaki, H. Kuzuya, 
H. Imura, G. I. Bell, and D. F. Steiner. 1988. Insulin-resistant diabetes 
due to a point mutation that prevents insulin proreceptor processing. 
Science (Wash. DC). 240:784-787. 
Bresnahan et al. Human Furin Encodes KEX2-1ike Endoprotease 2859 
